688626.SS SHH
Xiangyu Medical Co.,Ltd
1W: -4.7%
1M: -2.6%
3M: -14.0%
YTD: -38.3%
1Y: -27.0%
3Y: -3.0%
5Y: -48.2%
¥41.95 ($6.25)
-0.10 (-0.24%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$0
-100.0% ▼
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
$0
+100.0% ▲
Dividends Paid
$0
+100.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$703M
-1474.3% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $200M | $123M | $227M | $103M | $79M |
| Depreciation & Amort. | $11M | $16M | $20M | $40M | $0 |
| Stock-Based Comp. | $0 | $0 | $3M | $0 | $0 |
| Change in Working Capital | -$38M | $53M | -$31M | $12M | $0 |
| Other Non-Cash Items | -$7M | -$5M | $10M | $25M | -$79M |
| Operating Cash Flow | $166M | $187M | $228M | $179M | $0 |
| — Investing Activities — | |||||
| Capital Expenditures | -$134M | -$203M | -$479M | -$439M | $0 |
| Acquisitions (Net) | $40K | $4M | $0 | $0 | $0 |
| Investment Purchases | -$14M | -$3M | -$10M | -$200K | $0 |
| Investment Sales | $9M | $19M | $12M | $1M | $0 |
| Other Investing | -$643M | $5M | $243M | $162M | $0 |
| Investing Cash Flow | -$782M | -$179M | -$235M | -$276M | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $3M | $3M | $149M | $0 |
| Stock Repurchased | $0 | -$73M | -$26M | -$78M | $0 |
| Dividends Paid | -$59M | -$60M | -$40M | -$86M | $0 |
| Other Financing | $1.0B | $13M | -$21M | $163M | $0 |
| Financing Cash Flow | $955M | -$117M | -$59M | $148M | $0 |
| Net Change in Cash | $339M | -$109M | -$65M | $51M | -$703M |
| Cash End of Period | $826M | $717M | $652M | $703M | $0 |
| Free Cash Flow | $32M | -$16M | -$251M | -$260M | $0 |